In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
Alzheimer's & dementia : the journal of the Alzheimer's Association, 2020.
Alzheimer's diseaseSV2A[11C]UCB-J | PETsynaptic density
We were able to measure widespread synaptic loss due to AD using [ C]UCB-J PET. Future studies will continue to evaluate the utility of SV2A PET for tracking AD progression and for monitoring potential therapies.
Full Text (Upload PDF)
PPT (Upload PPT)